Buy & Sell Recursion Pharmaceuticals Inc (RXRX) – Recursion Pharmaceuticals Inc Price Today
Aura AI Summary
Key Stats
- $1.76BMarket Cap
- HealthSector
- -24.6%3M Drawdown
- $1.18BEnterprise Value
- -Dividend Yield
- 10 daysTypical Hold Time
Recursion Pharmaceuticals Inc (RXRX) is currently valued at a market capitalization of $1.76B, with an enterprise value of $1.18B. Over the past 52 weeks, Recursion Pharmaceuticals Inc has traded between a low of $2.84 and a high of $6.79, highlighting its annual price range. Over the past three months, Recursion Pharmaceuticals Inc has recorded a drawdown of -24.6%, reflecting recent price volatility. On average, investors hold Recursion Pharmaceuticals Inc for approximately 10 days, indicating typical investor behavior on the platform.
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Most Recent News
Global surgical masks market to reach $6.76B by 2034 with 5.5% CAGR amid rising healthcare demand.
The global surgical masks market, valued at $3.95 billion in 2024, is projected to grow at a 5.5% CAGR to reach $6.76 billion by 2034. Growth is driven by increased healthcare applications, rising infection control awareness, and more surgical proced...

Cathie Wood calls Fed's 2022 rate hikes a 'massive mistake' and praises new Chair Kevin Warsh to fix it.
Ark Invest CEO Cathie Wood criticized the Federal Reserve's 2022 interest rate hikes as a 'massive mistake,' arguing they worsened supply issues and caused unnecessary market volatility. She expressed confidence that new Fed Chairman Kevin Warsh, wit...

Lixiang Education regains Nasdaq compliance with $5M minimum market value of publicly held shares.
Lixiang Education Holding Co., Ltd. announced it has regained compliance with Nasdaq's minimum market value of publicly held shares requirement, reaching at least $5 million for 10 consecutive business days from May 21 to June 4, 2026. This follows a...
